Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage

Calcified Tissue International

Volumn 69, Issue 5, 2001, Pages 281-286

  Li, J ^a   Mashiba, T ^a   Burr, D B ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Bisphosphonate; Bone remodeling; Histomorphometry; Microdamage

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; RISEDRONIC ACID;

ANIMAL TISSUE; ARTICLE; BONE DEFECT; BONE INJURY; BONE REMODELING; CONTROLLED STUDY; DOG; DRUG EFFECT; MALE; MICROANALYSIS; MORPHOMETRICS; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; STATISTICS;

ALENDRONATE; ANIMALS; BONE DENSITY; BONE REGENERATION; DIPHOSPHONATES; DOGS; ETIDRONIC ACID; FEMALE; FRACTURES, BONE; RIB FRACTURES; STOCHASTIC PROCESSES;

EID: 0035210984     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002230010036     Document Type: Article

References (34)

1. Bone microdamage and skeletal fragility in osteoporotic and stress fractures
2. Age-related differences in post-yield damage in human cortical bone. Experiment and model
3. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib
4. The effects of damage and microcracking on the impact strength of bone
5. The effects of ageing and changes in mineral content in degrading the toughness of human femora
6. Bone microdamage: Factors that impair its repair
7. Transient-steady state phenomena in microdamage physiology: A proposed algorithm for lamellar bone
8. Some ABC's of skeletal pathophysiology. 5. Microdamage physiology
9. A brief review for orthopedic surgeons: Fatigue damage (microdamage) in bone (its determinants and clinical implications)
10. Cyclic mechanical property degradation during fatigue loading of cortical bone
11. Bone remodeling in response to in vivo fatigue microdamage
12. Intracortical remodeling in adult rat long bone after fatigue loading
13. Increased intracortical remodeling following fatigue damage
14. Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: Implications for mechanisms of bone loss
15. Skeletal heterogeneity and the purpose of bone remodeling: Implications for the understanding of osteoporosis
16. A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates
17. Bisphosphonates: Preclinical aspects and use in osteoporosis
18. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
19. Preadministration of incadronate disodium can prevent bone loss in rat proximal tibial metaphysis when induced by hindlimb immobilization by bandage
20. Risedronate treatment does not increase microdamage in the canine femoral neck
21. Alterations to the en bloc basic fuchsin staining protocol for the demonstration of microdamage produced in vivo
22. Validity of bulk-staining technique to separate artifactual from in vivo bone microdamage
23. Development of a fluorescent light technique for evaluating microdamage in bone subjected to fatigue loading
24. Calculating the probability that microcracks initiate resorption spaces
25. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone
26. Identification of apoptotic changes in osteocytes in normal and pathological human bone
27. DNA fragmentation during bone formation in neonatal rodents assessed by transferase-mediated end labeling
28. Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo
29. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles
30. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats
31. Bisphosphonates: Mechanisms of action